Keywords: ریلپیفیرین; Rilpivirine; Switch; Unboosted protease inhibitor; Ritonavir-sparing; Cholesterol; Triglycerides;
مقالات ISI ریلپیفیرین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ریلپیفیرین; Rilpivirine; Drug interaction; CYP; Drug transporter; PXR;
Structural analysis, solvent effects and intramolecular interactions in rilpivirine: A new non-nucleoside reverse transcriptase inhibitor for HIV treatment
Keywords: ریلپیفیرین; Rilpivirine; Conformer; Solvent effect; Intramolecular hydrogen bonding; DFT;
Ãvaluation à un an de l'information reçue par les patients ambulatoires sur l'interaction rilpivirine-modificateurs du pH gastrique
Keywords: ریلپیفیرین; Anti-acide; Anti-sécrétoire; Ãvaluation; Interaction médicamenteuse; Nourriture; Rilpivirine; PH gastrique; VIH; Antacid; Antisecretory; Evaluation; Drug interaction; Food; Gastric pH; HIV; Rilpivirine;
Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1
Keywords: ریلپیفیرین; Diarylpyrimidine (DAPY); Etravirine; Human immunodeficiency virus (HIV); Non-nucleoside reverse transcriptase inhibitors; NNRTIs; Rilpivirine
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Keywords: ریلپیفیرین; Naive adults; resistance mutations; rilpivirine; therapeutic barrier;
Preparation and characterization of rilpivirine solid dispersions with the application of enhanced solubility and dissolution rate
Keywords: ریلپیفیرین; Rilpivirine; Solid dispersion; Dissolution rate; Drug release kinetics
Emtricitabine/rilpivirine/tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults
Keywords: ریلپیفیرین; Emtricitabine; Rilpivirine; Tenofovir disoproxil fumarate; Complera; HIV
Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs
Keywords: ریلپیفیرین; HIV; human immunodeficiency virus; NNRTIs; non-nucleoside reverse transcriptase inhibitors; SARs; structure and activity relationships; HAART; highly active antiretroviral therapy; RT; reverse transcriptase; NVP; nevirapine; DLV; delavirdine; EFV; efavire
E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settings
Keywords: ریلپیفیرین; RT, reverse transcriptase; NNRTI, nonnucleoside reverse transcriptase inhibitor; RPV, rilpivirine; ETR, etravirine; EV, efavirenz; NVP, nevirapine; PrEP, pre-exposure prophylaxisHIV-1; Reverse transcriptase; NNRTI; Rilpivirine; E138A; Resistance
Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovir
Keywords: ریلپیفیرین; HIV; Reverse transcriptase; Synergy; Rilpivirine; Tenofovir; Emtricitabine
A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma
Keywords: ریلپیفیرین; Mass spectrometry; Dolutegravir; Rilpivirine;
Mecanismo de acción y farmacocinética de rilpivirina
Keywords: ریلپیفیرین; Efavirenz; Farmacocinética; Inhibidores no nucleósidos de la transcriptasa inversa; RilpivirinaEfavirenz; Pharmacokinetics; Nonnucleoside reverse transcriptase inhibitor; Rilpivirine
Perfil de seguridad de rilpivirina: tolerabilidad general y neuropsiquiátrica, seguridad en pacientes coinfectados con virus de la hepatitis B/virus de la hepatitis C, y perfil lipídico
Keywords: ریلپیفیرین; Coinfección; Rilpivirina; Seguridad; TolerabilidadCoinfection; Rilpivirine; Safety; Tolerability
Perfil de resistencia de rilpivirina
Keywords: ریلپیفیرین; VIH-1; Rilpivirina; Resistencia a antirretrovirales; Mutaciones de resistencia a VIH-1HIV-1; Rilpivirine; HIV-1 resistance; HIV-1-resistance mutations
Interacciones farmacocinéticas
Keywords: ریلپیفیرین; Rilpivirina; Interacciones medicamentosas; Infección VIH; Rilpivirine; Drug interactions; HIV infection;
Agonism of human pregnane X receptor by rilpivirine and etravirine: Comparison with first generation non-nucleoside reverse transcriptase inhibitors
Keywords: ریلپیفیرین; Rilpivirine; Etravirine; Efavirenz; Nevirapine; Delavirdine; Pregnane X receptor
Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection
Keywords: ریلپیفیرین; E138 mutation; Minority mutation; Pyrosequencing; Primary infection; Rilpivirine
Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era
Keywords: ریلپیفیرین; Rilpivirine; Tenfovir; Emtricitabine; Complera®; Eviplera®;
Validation of a rapid and sensitive high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds
Keywords: ریلپیفیرین; HPLC–MS/MS; Protein precipitation; Protease inhibitors; Etravirine; Rilpivirine; Maraviroc
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
Keywords: ریلپیفیرین; NNRTI; Efavirenz; Nevirapine; Etravirine; Rilpivirine; Next generation NNRTI
Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment
Keywords: ریلپیفیرین; Rilpivirine; Long-acting; Injectable; HIV; Pharmacokinetics